Characterizing Systemic Immune Dysfunction Syndrome to Fill in the Gaps of SEPSIS-2 and SEPSIS-3 Definitions

Chest

Volumn 151, Issue 2, 2017, Pages 518-519

  Bermejo Martin, Jesús F ^a   Tamayo, Eduardo ^a   Andaluz Ojeda, David ^a   Martín Fernández, Marta ^a   Almansa, Raquel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LACTIC ACID;

BLOOD PRESSURE; HUMAN; IMMUNE DYSREGULATION; INFECTION; INTENSIVE CARE; LETTER; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC IMMUNE DYSFUNCTION SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYPNEA; SEPTIC SHOCK; SYNDROME;

HUMANS; SEPSIS; SHOCK, SEPTIC; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 85011591501     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.11.047     Document Type: Letter

References (5)

1. 1 Simpson, S.Q., New sepsis criteria: a change we should not make. Chest 149:5 (2016), 1117–1118.
2. 2 Vincent, J.L., Opal, S.M., Marshall, J.C., Tracey, K.J., Sepsis definitions: time for change. Lancet Lond Engl 381:9868 (2013), 774–775.
3. 3 Bermejo-Martin, J.F., Andaluz-Ojeda, D., Almansa, R., et al. Defining immunological dysfunction in sepsis: a requisite tool for precision medicine. J Infect 72:5 (2016), 525–536.
4. 4 Almansa, R., Wain, J., Tamayo, E., et al. Immunological monitoring to prevent and treat sepsis. Crit Care Lond Engl, 17(1), 2013, 109.
5. 5 Bermejo-Martin, J.F., Andaluz-Ojeda, D., Almansa, R., Eiros, J.M., Tamayo, E., Preventing sepsis. Lancet Infect Dis 15:11 (2015), 1259–1260.